ARS Pharmaceuticals reported total assets of $249.50M and total liabilities of $236.98M for the quarter ended Jun 2026, down 20.4% year over year. This balance sheet covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 300.66M | 60.06M | 233.99M | 218.69M | 203.22M | 210.52M | 87.86M | 119.02M | 60.53M | 70.97M | 56.01M | 36.63M | 39.66M | 50.82M | 39.86M | 51.54M | 59.56M | 41.32M | 24.32M | 8.16M | ||||||
| Short-term InvestmentsInvestments (Current) | 19.86M | 39.28M | 63.40M | 63.86M | 176.69M | 133.19M | 181.37M | 157.39M | 167.63M | 182.12M | 164.97M | 263.20M | 235.86M | 188.59M | 228.65M | 203.67M | 176.65M | 135.68M | ||||||||
| Cash & Current Investments | 300.66M | 60.06M | 253.85M | 257.98M | 266.62M | 274.38M | 264.55M | 252.21M | 241.90M | 228.36M | 223.63M | 218.74M | 204.62M | 314.02M | 275.73M | 240.13M | 288.21M | 244.99M | 200.97M | 143.84M | ||||||
| Receivables - NetNet Receivables | 0.77M | 8.18M | 9.30M | 25.13M | 36.45M | 25.35M | 28.66M | 46.84M | ||||||||||||||||||
| Receivables - OtherOther Receivables | 0.16M | 0.21M | 0.31M | 0.35M | 0.21M | 0.65M | 0.28M | 0.12M | 0.15M | 1.23M | 0.96M | 2.03M | 4.27M | |||||||||||||
| Receivables | 0.65M | 0.93M | 9.41M | 10.27M | 27.15M | 40.72M | 25.35M | 28.66M | 46.84M | |||||||||||||||||
| Raw Materials | 0.42M | |||||||||||||||||||||||||
| Work In Process | 0.29M | |||||||||||||||||||||||||
| Finished Goods | 5.21M | 7.27M | ||||||||||||||||||||||||
| Inventory | 0.71M | 5.21M | 7.27M | 8.74M | 7.78M | 8.37M | 8.82M | 11.69M | ||||||||||||||||||
| Prepaid Assets | 4.70M | 0.67M | 7.49M | 5.15M | 4.17M | 3.32M | 2.80M | 2.83M | 2.56M | 3.37M | 2.61M | 1.99M | 2.68M | 6.89M | 11.56M | 7.44M | 6.42M | 6.19M | 6.79M | 9.14M | ||||||
| Current Assets | 305.36M | 60.73M | 261.33M | 263.13M | 270.80M | 277.70M | 267.35M | 255.03M | 244.47M | 231.73M | 226.24M | 220.74M | 208.79M | 334.30M | 303.86M | 281.44M | 338.86M | 284.90M | 245.24M | 211.51M | ||||||
| Non-Current Assets | ||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 1.91M | 0.07M | 2.43M | 2.48M | 0.01M | 0.33M | 0.58M | 0.59M | 0.62M | 0.57M | 0.62M | 0.64M | 0.84M | 1.07M | 1.07M | 1.07M | 1.21M | 2.46M | 2.29M | 2.08M | ||||||
| Long-Term Investments | 39.94M | 64.78M | 43.97M | 24.22M | 5.31M | 11.94M | 13.37M | 13.64M | 23.05M | 23.22M | 19.05M | |||||||||||||||
| Intangibles | 0.62M | 0.53M | 0.45M | 7.50M | 7.37M | 7.24M | 12.97M | 14.73M | 14.45M | 14.18M | 13.90M | |||||||||||||||
| Goodwill & Intangibles | 0.62M | 7.37M | 7.24M | 12.97M | 14.73M | 14.45M | 14.18M | 13.90M | ||||||||||||||||||
| Long-Term Deferred Tax | 29.04M | 36.86M | 73.41M | |||||||||||||||||||||||
| Other Non-Current Assets | 0.35M | 0.02M | 0.25M | 0.25M | 2.40M | 2.96M | 2.86M | 2.77M | 3.17M | 0.64M | 0.53M | 0.45M | 0.38M | 3.11M | 3.13M | 3.05M | 2.92M | 2.79M | 2.65M | 2.96M | ||||||
| Non-Current Assets | 47.21M | 0.72M | 51.14M | 30.87M | 0.27M | 3.73M | 3.84M | 3.72M | 4.09M | 1.46M | 1.34M | 1.23M | 8.81M | 16.86M | 23.46M | 32.04M | 33.94M | 42.76M | 42.34M | 37.98M | ||||||
| Assets | 352.56M | 61.45M | 312.47M | 294.00M | 271.06M | 281.44M | 271.19M | 258.75M | 248.56M | 233.19M | 227.58M | 221.97M | 217.60M | 351.15M | 327.32M | 313.47M | 372.80M | 327.65M | 287.57M | 249.50M | ||||||
| Liabilities | ||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||
| Accounts Payables | 1.72M | 3.11M | 2.63M | 2.11M | 0.13M | 4.93M | 9.60M | 9.82M | 10.95M | 2.15M | 3.50M | 6.57M | 16.52M | 22.84M | 27.01M | 44.26M | 49.77M | 37.95M | 48.26M | 59.73M | ||||||
| Notes Payables | 3.48M | |||||||||||||||||||||||||
| Payables | 1.72M | 6.59M | 2.63M | 2.11M | 0.13M | 4.93M | 9.60M | 9.82M | 10.95M | 2.15M | 3.50M | 6.57M | 16.52M | 22.84M | 27.01M | 44.26M | 49.77M | 37.95M | 48.26M | 59.73M | ||||||
| Accumulated Expenses | 12.54M | 11.73M | 0.40M | 0.60M | 3.65M | 12.00M | 4.07M | 11.27M | 6.88M | 20.41M | 13.48M | |||||||||||||||
| Other Accumulated Expenses | 0.04M | 3.08M | 1.45M | 0.59M | 3.79M | |||||||||||||||||||||
| Short term Debt | ||||||||||||||||||||||||||
| Current Leases | 1.09M | 0.14M | 1.12M | 0.88M | 0.21M | 0.23M | 0.23M | 0.23M | 0.23M | 0.24M | 0.22M | 0.16M | 0.10M | 0.04M | 0.07M | 0.59M | 0.58M | |||||||||
| Current Deferred Revenue | 1.46M | 3.14M | 0.01M | 0.56M | 0.54M | 0.75M | 0.53M | 0.61M | 0.76M | 0.54M | ||||||||||||||||
| Total Current Liabilities | 15.35M | 8.19M | 14.81M | 11.14M | 3.99M | 5.44M | 9.84M | 10.05M | 11.18M | 2.39M | 3.71M | 6.72M | 16.62M | 23.44M | 27.62M | 45.60M | 50.88M | 39.15M | 49.61M | 60.86M | ||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||
| Non-Current Debt | 4.93M | 69.38M | 69.38M | 71.96M | 96.23M | 96.37M | 96.52M | 96.68M | ||||||||||||||||||
| Non-Current Deffered Revenue | 3.00M | 2.85M | 1.53M | 1.34M | 1.10M | 1.27M | 1.13M | 0.98M | 1.11M | |||||||||||||||||
| Preferred Stock Liabilities | 54.81M | |||||||||||||||||||||||||
| Operating Leases | 5.08M | 0.48M | 4.43M | 4.07M | 0.25M | 0.43M | 0.15M | 0.09M | 0.04M | 1.07M | 0.95M | |||||||||||||||
| Other Non-Current Liabilities | 0.08M | 1.42M | 3.78M | 4.61M | 4.48M | 3.40M | ||||||||||||||||||||
| Total Non-Current Liabilities | 16.59M | 8.55M | 94.36M | 119.73M | 221.37M | 208.79M | 221.78M | 233.58M | ||||||||||||||||||
| Total Liabilities | 20.43M | 16.68M | 19.24M | 15.21M | 3.99M | 8.55M | 10.04M | 10.20M | 11.27M | 2.43M | 3.71M | 6.72M | 16.62M | 94.36M | 98.34M | 121.15M | 225.15M | 213.39M | 226.26M | 236.98M | ||||||
| Shareholder's Equity | ||||||||||||||||||||||||||
| Total Debt | 8.41M | 69.38M | 69.38M | 71.96M | 96.23M | 96.37M | 96.52M | 96.68M | ||||||||||||||||||
| Common Equity | 332.13M | -31.27M | -38.26M | -44.03M | -50.16M | 272.89M | 261.15M | 248.55M | 237.28M | 230.76M | 223.87M | 215.24M | 200.98M | 256.80M | 228.97M | 192.32M | 147.66M | 114.26M | 61.31M | 12.51M | ||||||
| Liabilities and Shareholders Equity | 352.56M | 61.45M | 312.47M | 294.00M | 271.06M | 281.44M | 271.19M | 258.75M | 248.56M | 233.19M | 227.58M | 221.97M | 217.60M | 351.15M | 327.32M | 313.47M | 372.80M | 327.65M | 287.57M | 249.50M | ||||||
| Retained Earnings | 494.92M | -42.26M | 505.32M | 510.61M | 516.83M | 349.41M | 352.98M | 357.99M | 361.57M | 362.00M | 365.58M | 369.49M | 373.87M | 379.87M | 386.14M | 394.49M | 400.93M | 408.73M | 416.62M | 430.20M | ||||||
| Treasury Shares | 9.34M | 9.34M | 9.34M | 9.34M | 30.76M |